Alexander Blake, PhD

Alexander Blake, PhD

Analyst, Public Equity

Alex joined Sofinnova BioEquities in 2021 as an Analyst. He focuses on public investments in global biotech and pharmaceutical companies.

Prior to Sofinnova, Alex was a Senior Equity Research Associate at Raymond James focused on Biotech Equity Research. Before Raymond James, Alex was a Technology and Product Development Staff Engineer at BECTON, DICKINSON, & COMPANY covering BD Life Sciences. He began his career as a Bioengineering Scientist on the Canon Biomedical team at Canon USA Inc

Alex received his MS and PhD in Biomedical Engineering from the University of Wisconsin along with a B.S. in Applied Sciences from the University of North Carolina.